ICU Medical, Inc. (ICUI) Shares Bought by Riverhead Capital Management LLC
Riverhead Capital Management LLC raised its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 99.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 999 shares of the medical instruments supplier’s stock after purchasing an additional 499 shares during the period. Riverhead Capital Management LLC’s holdings in ICU Medical were worth $172,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Personal Capital Advisors Corp purchased a new position in shares of ICU Medical during the second quarter valued at about $1,494,000. Royce & Associates LP increased its holdings in shares of ICU Medical by 26.7% in the second quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock worth $8,177,000 after purchasing an additional 10,000 shares during the last quarter. Schwab Charles Investment Management Inc. increased its holdings in shares of ICU Medical by 8.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 62,048 shares of the medical instruments supplier’s stock worth $9,475,000 after purchasing an additional 4,829 shares during the last quarter. KBC Group NV increased its holdings in shares of ICU Medical by 66.0% in the first quarter. KBC Group NV now owns 4,338 shares of the medical instruments supplier’s stock worth $662,000 after purchasing an additional 1,724 shares during the last quarter. Finally, Texas Permanent School Fund increased its holdings in shares of ICU Medical by 0.3% in the first quarter. Texas Permanent School Fund now owns 10,747 shares of the medical instruments supplier’s stock worth $1,641,000 after purchasing an additional 28 shares during the last quarter. 78.13% of the stock is owned by institutional investors and hedge funds.
ICU Medical, Inc. (NASDAQ ICUI) opened at 185.85 on Monday. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 74.43 and a beta of 0.35. The company has a 50 day moving average of $173.09 and a 200-day moving average of $164.39. ICU Medical, Inc. has a 12-month low of $124.68 and a 12-month high of $188.85.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. During the same quarter last year, the company earned $1.15 EPS. The firm’s revenue for the quarter was up 242.8% on a year-over-year basis. On average, equities research analysts forecast that ICU Medical, Inc. will post $4.11 earnings per share for the current year.
A number of equities research analysts recently commented on the company. Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a research report on Monday, September 11th. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday, June 17th. Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $193.00.
In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the transaction, the vice president now owns 102 shares in the company, valued at $17,795.94. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Vivek Jain sold 69,014 shares of the firm’s stock in a transaction that occurred on Friday, July 7th. The shares were sold at an average price of $171.10, for a total value of $11,808,295.40. Following the completion of the transaction, the chief executive officer now owns 110,925 shares in the company, valued at approximately $18,979,267.50. The disclosure for this sale can be found here. Insiders sold a total of 213,012 shares of company stock worth $36,438,659 over the last ninety days. 15.90% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “ICU Medical, Inc. (ICUI) Shares Bought by Riverhead Capital Management LLC” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.watchlistnews.com/icu-medical-inc-icui-shares-bought-by-riverhead-capital-management-llc/1602388.html.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.